mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |